Novogene Co., Ltd.

Total Valuation

Novogene Co., Ltd. carries a market capitalization of 5.59B, placing it among publicly traded companies globally. Its enterprise value stands at 4.58B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Novogene Co., Ltd. currently has 416.20M shares outstanding.

Valuation Ratios

Novogene Co., Ltd. trades at a trailing price-to-earnings ratio of 30.26. The price-to-sales ratio is 2.77, and the price-to-book ratio stands at 4.15.

Enterprise Valuation

On an enterprise value basis, Novogene Co., Ltd. trades at an EV/EBITDA multiple of 21.29 and an EV/FCF ratio of 39.72. The EV/Sales ratio of 2.13 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.29 provides insight into valuation relative to core operating earnings.

Financial Position

Novogene Co., Ltd. maintains a current ratio of 2.64, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.83, indicating elevated leverage, while an interest coverage ratio of 152.63 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Novogene Co., Ltd. posts a return on equity of 14.56 and a return on invested capital of 7.78.

Taxes

Over the trailing twelve months, Novogene Co., Ltd. has paid 18.97M in income taxes, reflecting an effective tax rate of 8.54.

Stock Price Statistics

Novogene Co., Ltd.'s stock has declined approximately -6.47182% over the past 52 weeks. The 50-day moving average sits at 13.90, while the 200-day moving average is 14.40.

Income Statement

Over the trailing twelve months, Novogene Co., Ltd. generated 2.15B in revenue and converted that into 197.59M in net income, yielding earnings per share of 0.48. EBITDA reached 215.28M, while operating income came in at 215.28M.

Balance Sheet

Novogene Co., Ltd. holds 1.47B in cash and equivalents against 47.43M in total debt, resulting in a net debt position of -469.53M. Total book value stands at 1.44B, with working capital of 1.64B providing operational flexibility.

Cash Flow

After subtracting -114.11M in capital expenditures, free cash flow totaled -114.11M - equivalent to -0.27 per share.

Margins

Novogene Co., Ltd. operates with a gross margin of 43.26, reflecting its pricing power and cost economics. The operating margin of 9.99 and net profit margin of 9.17 provide insight into operational efficiency.

Dividends & Yields

Scores

Novogene Co., Ltd. posts an Altman Z-Score of 5.23, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.